These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
960 related articles for article (PubMed ID: 20876699)
21. Sugammadex: the first selective binding reversal agent for neuromuscular block. Kovac AL J Clin Anesth; 2009 Sep; 21(6):444-53. PubMed ID: 19833281 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial. Czarnetzki C; Tassonyi E; Lysakowski C; Elia N; Tramèr MR Anesthesiology; 2014 Jul; 121(1):59-67. PubMed ID: 24608361 [TBL] [Abstract][Full Text] [Related]
23. Neuromuscular transmission: new concepts and agents. de Boer HD J Crit Care; 2009 Mar; 24(1):36-42. PubMed ID: 19272537 [TBL] [Abstract][Full Text] [Related]
24. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Sorgenfrei IF; Norrild K; Larsen PB; Stensballe J; Ostergaard D; Prins ME; Viby-Mogensen J Anesthesiology; 2006 Apr; 104(4):667-74. PubMed ID: 16571960 [TBL] [Abstract][Full Text] [Related]
25. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Pühringer FK; Rex C; Sielenkämper AW; Claudius C; Larsen PB; Prins ME; Eikermann M; Khuenl-Brady KS Anesthesiology; 2008 Aug; 109(2):188-97. PubMed ID: 18648227 [TBL] [Abstract][Full Text] [Related]
26. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. Plaud B; Meretoja O; Hofmockel R; Raft J; Stoddart PA; van Kuijk JH; Hermens Y; Mirakhur RK Anesthesiology; 2009 Feb; 110(2):284-94. PubMed ID: 19194156 [TBL] [Abstract][Full Text] [Related]
27. Sugammadex reverses neuromuscular block induced by 3-desacetyl-vecuronium, an active metabolite of vecuronium, in the anaesthetised rhesus monkey. Staals LM; van Egmond J; Driessen JJ; de Boer HD; van de Pol F; Bom AH; Booij LH Eur J Anaesthesiol; 2011 Apr; 28(4):265-72. PubMed ID: 21157358 [TBL] [Abstract][Full Text] [Related]
28. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery. Rahe-Meyer N; Berger C; Wittmann M; Solomon C; Abels EA; Rietbergen H; Reuter DA Anaesthesist; 2015 Jul; 64(7):506-12. PubMed ID: 26126940 [TBL] [Abstract][Full Text] [Related]
29. Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia. Rex C; Wagner S; Spies C; Scholz J; Rietbergen H; Heeringa M; Wulf H Anesthesiology; 2009 Jul; 111(1):30-5. PubMed ID: 19512873 [TBL] [Abstract][Full Text] [Related]
30. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics. Sparr HJ; Vermeyen KM; Beaufort AM; Rietbergen H; Proost JH; Saldien V; Velik-Salchner C; Wierda JM Anesthesiology; 2007 May; 106(5):935-43. PubMed ID: 17457124 [TBL] [Abstract][Full Text] [Related]
31. Flucloxacillin and diclofenac do not cause recurrence of neuromuscular blockade after reversal with sugammadex. Kam PJ; Heuvel MW; Grobara P; Zwiers A; Jadoul JL; Clerck Ed; Ramael S; Peeters PA Clin Drug Investig; 2012 Mar; 32(3):203-12. PubMed ID: 22201295 [TBL] [Abstract][Full Text] [Related]
32. Reversal of Pipecuronium-Induced Moderate Neuromuscular Block with Sugammadex in the Presence of a Sevoflurane Anesthetic: A Randomized Trial. Tassonyi E; Pongrácz A; Nemes R; Asztalos L; Lengyel S; Fülesdi B Anesth Analg; 2015 Aug; 121(2):373-80. PubMed ID: 25923435 [TBL] [Abstract][Full Text] [Related]
33. Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation. Pongrácz A; Szatmári S; Nemes R; Fülesdi B; Tassonyi E Anesthesiology; 2013 Jul; 119(1):36-42. PubMed ID: 23665915 [TBL] [Abstract][Full Text] [Related]
35. Dexamethasone does not diminish sugammadex reversal of neuromuscular block - clinical study in surgical patients undergoing general anesthesia. Rezonja K; Mars T; Jerin A; Kozelj G; Pozar-Lukanovic N; Sostaric M BMC Anesthesiol; 2016 Oct; 16(1):101. PubMed ID: 27765010 [TBL] [Abstract][Full Text] [Related]
36. A randomized, dose-finding, phase II study of the selective relaxant binding drug, Sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. Groudine SB; Soto R; Lien C; Drover D; Roberts K Anesth Analg; 2007 Mar; 104(3):555-62. PubMed ID: 17312208 [TBL] [Abstract][Full Text] [Related]
37. Sugammadex reversal of rocuronium-induced neuromuscular block in Caesarean section patients: a series of seven cases. Pühringer FK; Kristen P; Rex C Br J Anaesth; 2010 Nov; 105(5):657-60. PubMed ID: 20736231 [TBL] [Abstract][Full Text] [Related]